The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report
2006

Potential Cancer Risk from Tacrolimus Ointment

publication Evidence: low

Author Information

Author(s): Becker Jürgen C, Houben Roland, Vetter Claudia S, Bröcker Eva B

Primary Institution: Department of Dermatology, Julius-Maximilians-University, Würzburg, Germany

Hypothesis

The carcinogenic potential of tacrolimus may go beyond mere immune suppression.

Conclusion

The study suggests a possible link between the use of tacrolimus and the development of squamous cell carcinoma.

Supporting Evidence

  • Tacrolimus ointment is used for various inflammatory skin diseases.
  • The FDA has warned about a potential cancer risk associated with tacrolimus.
  • The patient developed squamous cell carcinoma after prolonged use of tacrolimus.

Takeaway

Using tacrolimus ointment might increase the risk of getting cancer, not just because it weakens the immune system, but also for other reasons.

Methodology

Case report of a patient treated with tacrolimus ointment for oral lichen planus who later developed squamous cell carcinoma.

Potential Biases

Potential bias due to the nature of a case report and lack of control group.

Limitations

The study is based on a single case report, which limits the generalizability of the findings.

Participant Demographics

One 56-year-old female patient.

Digital Object Identifier (DOI)

10.1186/1471-2407-6-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication